biotech News
Most Popular biotech Story
Should Pharma take the M&A cure?
What's Big Pharma's best hope for weathering the next few years of expiring patents and patchy pipelines? M&A, says London's Financial Times. That's not exactly revolutionary, of course; there... Read more...
Latest Headlines
- October 1, 2007
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
